Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: Comparison to antibody-secreting cell responses and other immunological markers

Infection and Immunity

Volumn 71, Issue 8, 2003, Pages 4808-4814

  Qadri, Firdausi ^a,e   Ryan, Edward T ^b,c   Faruque, A S G ^a   Ahmed, Firoz ^a   Khan, Ashraful Islam ^a   Islam, M Monirul ^a   Akramuzzaman, Syed M ^a   Sack, David A ^a   Calderwood, Stephen B ^b,d  

^a ICDDR B Centre for Health and Population Research   (Bangladesh)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e ICDDRB Laboratory Sciences Division   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHOLERA TOXIN B SUBUNIT; HEMAGGLUTININ; IMMUNOGLOBULIN A;

ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCING CELL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BANGLADESH; CHOLERA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LYMPHOCYTE CULTURE; LYMPHOCYTE MIGRATION; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SUPERNATANT; VIBRIO CHOLERAE;

ADULT; ANTIBODY SPECIFICITY; ANTIBODY-PRODUCING CELLS; ANTIGENS, BACTERIAL; B-LYMPHOCYTES; BACTERIAL PROTEINS; BANGLADESH; BIOLOGICAL MARKERS; BLOOD BACTERICIDAL ACTIVITY; CASE-CONTROL STUDIES; CHOLERA; CHOLERA TOXIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; FIMBRIAE PROTEINS; HEMAGGLUTININS; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; LIPOPOLYSACCHARIDES; MALE; MANNOSE-BINDING LECTIN; VIBRIO CHOLERAE;

EID: 0042745625     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.8.4808-4814.2003     Document Type: Article

References (22)

1. Angelakopoulos, H., and E. L. Hohmann. 2000. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect. Immun. 68:2135-2141.
2. Benenson, A. S., M. R. Islam, and W. B. Greenough III. 1964. Rapid identification of Vibrio cholerae by darkfield microscopy. Bull. W. H. O. 30:827-831.
3. Chang, H. S., and D. A. Sack. 2001. Development of a novel in vitro assay (ALS assay) for evaluation of vaccine-induced antibody secretion from circulating mucosal lymphocytes. Clin. Diagn. Lab. Immunol. 8:482-488.
4. Crean, T. I., M. John, S. B. Calderwood, and E. T. Ryan. 2000. Optimizing the germfree mouse model for in vivo evaluation of oral Vibrio cholerae vaccine and vector strains. Infect. Immun. 68:977-981.
5. Czerkinsky, C., Z. Moldoveanu, J. Mestecky, L. A. Nilsson, and O. Ouchterlony. 1988. A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells. J. Immunol. Methods 115:31-37.
6. Czerkinsky, C., S. J. Prince, S. M. Michalek, S. Jackson, Z. Moldoveanu, M. W. Russell, J. R. McGhee, and J. Mestecky. 1987. Oral immunization with bacterial antigen induces IgA-secreting cells in peripheral blood in humans. Adv. Exp. Med. Biol. 216B:1709-1719.
7. DiPetrillo, M. D., T. Tibbetts, H. Kleanthous, K. P. Killeen, and E. L. Hohmann. 1999. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers. Vaccine 18:449-459.
8. Forrest, B. D. 1988. Identification of an intestinal immune response using peripheral blood lymphocytes. Lancet i:81-83.
9. Forrest, B. D. 1992. Indirect measurement of intestinal immune responses to an orally administered attenuated bacterial vaccine. Infect. Immun. 60:2023-2029.
10. Glass, R. I., A. M. Svennerholm, M. R. Khan, S. Huda, M. I. Huq, and J. Holmgren. 1985. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. J. Infect. Dis. 151:236-242.
11. Jertborn, M., A. M. Svennerholm, and J. Holmgren. 1986. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J. Clin. Microbiol. 24:203-209.
12. John, M., T. I. Crean, S. B. Calderwood, and E. T. Ryan. 2000. In vitro and in vivo analyses of constitutive and in vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae. Infect. Immun. 68:1171-1175.
13. Jonson, G., M. Lebens, and J. Holmgren. 1994. Cloning and sequencing of Vibrio cholerae mannose-sensitive haemagglutinin pilin gene: localization of mshA within a cluster of type 4 pilin genes. Mol. Microbiol. 13:109-118.
14. Levine, M. M., J. B. Kaper, R. E. Black, and M. L. Clements. 1983. New knowledge on pathogenesis of bacterial infections as applied to vaccine development. Microbiol. Rev. 47:510-550.
15. Monsur, K. A. 1961. A highly selective gelatin-taurocholate tellurite medium for the isolation of Vibrio cholerae. Trans. R. Soc. Trop. Med. Hyg. 55:440-442.
16. Qadri, F., F. Ahmed, M. M. Karim, C. Wenneras, Y. A. Begum, S. M. Abdus, M. J. Albert, and J. R. McGhee. 1999. Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera. Clin. Diagn. Lab. Immunol. 6:812-818.
17. Qadri, F., T. Azim, A. Chowdhury, J. Hossain, R. B. Sack, and M. J. Albert. 1994. Production, characterization, and application of monoclonal antibodies to Vibrio cholerae 0139 synonym Bengal. Clin. Diagn. Lab. Immunol. 1:51-54.
18. Qadri, F., G. Jonson, Y. A. Begum, C. Wenneras, M. J. Albert, M. A. Salam, and A. M. Svennerholm. 1997. Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O139. Clin. Diagn. Lab. Immunol. 4:429-434.
19. Qadri, F., G. Mohi, J. Hossain, T. Azim, A. M. Khan, M. A. Salam, R. B. Sack, M. J. Albert, and A. M. Svennerholm. 1995. Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1. Clin. Diagn. Lab. Immunol. 2:685-688.
20. Qadri, F., C. Wenneras, M. J. Albert, J. Hossain, K. Mannoor, Y. A. Begum, G. Mohi, M. A. Salam, R. B. Sack, and A. M. Svennerholm. 1997. Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. Infect. Immun. 65:3571-3576.
21. Svennerholm, A. M., M. Jertborn, L. Gothefors, A. M. Karim, D. A. Sack, and J. Holmgren. 1984. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J. Infect. Dis. 149:884-893.
22. Turner, A. K., T. D. Terry, D. A. Sack, P. Londono-Arcila, and M. J. Darsley. 2001. Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans. Infect. Immun. 69:4969-4979.